Clozapine modified-release (Intas Pharmaceuticals)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameClozapine modified-release (Intas Pharmaceuticals)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 2a (5-HT2a) receptor antagonistsDopamine D2 receptor antagonistsAlpha adrenergic receptor antagonists
TargetsSerotonin 2a (5-HT2a) receptorDopamine D2 receptorAlpha adrenergic receptor
Therapy Area/IndicationsSchizophrenia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesIntas Biopharmaceuticals
China Registration ClassN/A

Develop Information

Active CompaniesIntas Biopharmaceuticals
Inactive CompaniesN/A
Active IndicationsSchizophrenia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksWikipediaDrugBankKEGG